INTRODUCTION: Tenofovir and entecavir are potent antiviral agents. By suppressing viral replication, they induce histological improvement and finally delay the progression of chronic hepatitis B and the development of complications. They are rarely associated with serious side effects. Our data from a real life experience support data from the literature and suggest some minimal difference that may be useful in tailoring therapy. PATIENTS AND METHODS: We retrospectively analyzed 54 patients affected by chronic hepatitis B (31 and 23 treated by entecavir and tenofovir, respectively). Eight patients were cirrhotic. At baseline and 4-12 and 24 weeks after starting therapy, biochemical and virological analysis were performed in all patients. Re...
Background/Aim: The goal of antiviral therapy for chronic hepatitis B (CHB) is to improve survival o...
Objective: To compare responses to tenofovir (TDF) and entecavir (ETV) therapy. Methods: This was a ...
Background: Limited data exist regarding tenofovir disoproxil fumarate (TDF) safety and effectivenes...
Chronic Hepatitis B (CHB) affects 350-400 million of patients worldwide. Entecavir (ETV) and tenofov...
İstanbul Bilim Üniversitesi, Tıp Fakültesi.Background Hepatitis B virus (HBV) infection is a health ...
Objective: To compare the effectiveness and renal safety of treatment with tenofovir versus entecavi...
Background: An important goal in the treatment of chronic hepatitis B virus (HBV) infection is to pr...
Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are potent nucleos(t)ide analogues (NUCs) re...
Tenofovir (TDF) and entecavir (ETV) are both potent antiviral agents for the treatment of chronic he...
Tenofovir (TDF) and entecavir (ETV) are both potent antiviral agents for the treatment of chronic he...
Background/Aims: This study aimed to evaluate the antiviral response and safety of tenofovir (TDF) v...
SummaryObjectiveTo compare responses to tenofovir (TDF) and entecavir (ETV) therapy.MethodsThis was ...
Objective: To compare responses to tenofovir (TDF) and entecavir (ETV) therapy. Methods: This was a ...
Objective: To compare responses to tenofovir (TDF) and entecavir (ETV) therapy. Methods: This was a ...
This study aimed to evaluate the efficacy and safety of entecavir and/or tenofovir in compensated (C...
Background/Aim: The goal of antiviral therapy for chronic hepatitis B (CHB) is to improve survival o...
Objective: To compare responses to tenofovir (TDF) and entecavir (ETV) therapy. Methods: This was a ...
Background: Limited data exist regarding tenofovir disoproxil fumarate (TDF) safety and effectivenes...
Chronic Hepatitis B (CHB) affects 350-400 million of patients worldwide. Entecavir (ETV) and tenofov...
İstanbul Bilim Üniversitesi, Tıp Fakültesi.Background Hepatitis B virus (HBV) infection is a health ...
Objective: To compare the effectiveness and renal safety of treatment with tenofovir versus entecavi...
Background: An important goal in the treatment of chronic hepatitis B virus (HBV) infection is to pr...
Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are potent nucleos(t)ide analogues (NUCs) re...
Tenofovir (TDF) and entecavir (ETV) are both potent antiviral agents for the treatment of chronic he...
Tenofovir (TDF) and entecavir (ETV) are both potent antiviral agents for the treatment of chronic he...
Background/Aims: This study aimed to evaluate the antiviral response and safety of tenofovir (TDF) v...
SummaryObjectiveTo compare responses to tenofovir (TDF) and entecavir (ETV) therapy.MethodsThis was ...
Objective: To compare responses to tenofovir (TDF) and entecavir (ETV) therapy. Methods: This was a ...
Objective: To compare responses to tenofovir (TDF) and entecavir (ETV) therapy. Methods: This was a ...
This study aimed to evaluate the efficacy and safety of entecavir and/or tenofovir in compensated (C...
Background/Aim: The goal of antiviral therapy for chronic hepatitis B (CHB) is to improve survival o...
Objective: To compare responses to tenofovir (TDF) and entecavir (ETV) therapy. Methods: This was a ...
Background: Limited data exist regarding tenofovir disoproxil fumarate (TDF) safety and effectivenes...